✦ LIBER ✦

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

✍ Scribed by Stupp, R.

Book ID: 125836044
Publisher: American Society of Clinical Oncology
Year: 2002
Tongue: English
Weight: 110 KB
Volume: 20
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.20.5.1375

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Encouraging experience of concomitant Te

Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience

✍ Jalali, R.; Basu, A.; Gupta, T.; Munshi, A.; Menon, H.; Sarin, R.; Goel, A. 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 213 KB

163 OUTCOMES AND PREDICTORS OF SURVIVAL

163 OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

✍ Swaminath, A.; McMillan, W.; McCarter, H.; Hirte, H.; Whitton, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Health-Related Quality of Life in Elderl

✍ Minniti, Giuseppe; Scaringi, Claudia; Baldoni, Alessandra; Lanzetta, Gaetano; De 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Toxicity and survival in primary gliobla

Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis

✍ Gutenberg, A.; Bock, H. C.; Reifenberger, G.; BrÃ¼ck, W.; Giese, A. 📂 Article 📅 2012 🏛 Springer Vienna 🌐 English ⚖ 230 KB

Overall survival of newly diagnosed glio

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

✍ Mary Lou Affronti; Christopher R. Heery; James E. Herndon II; Jeremy N. Rich; Da 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

## Abstract ## BACKGROUND: Glioblastoma multiforme (GBM), the most lethal type of brain tumor, has a 1‐year median survival. The effect of carmustine wafers on the survival of newly diagnosed GBM patients treated with radiotherapy (RT) and concurrent temozolomide (TMZ) plus RT plus rotational chem

Phase II and pharmacogenomics study of e

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

✍ Butowski, N.; Chang, S. M.; Lamborn, K. R.; Polley, M.-Y.; Pieper, R.; Costello, 📂 Article 📅 2011 🏛 Duke University Press 🌐 English ⚖ 173 KB